BIRM 271

CAS No. 149106-77-4

BIRM 271( —— )

Catalog No. M37008 CAS No. 149106-77-4

BIRM 271 is a novel arachidonic acid release inhibitor that blocks leukotriene B4 and platelet-activating factor biosynthesis in human neutrophils.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 296 Get Quote
5MG 409 Get Quote
10MG 604 Get Quote
25MG 908 Get Quote
50MG 1251 Get Quote
100MG 1647 Get Quote
500MG 3312 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    BIRM 271
  • Note
    Research use only, not for human use.
  • Brief Description
    BIRM 271 is a novel arachidonic acid release inhibitor that blocks leukotriene B4 and platelet-activating factor biosynthesis in human neutrophils.
  • Description
    BIRM 271 is a novel arachidonic acid release inhibitor that blocks leukotriene B4 and platelet-activating factor biosynthesis in human neutrophils. BIRM 271 and BIRM 270 are enantiomers that inhibit the production of leukotriene B4 with IC50 of 40 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Phospholipase
  • Recptor
    Phospholipase | LTR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    149106-77-4
  • Formula Weight
    335.44
  • Molecular Formula
    C21H25N3O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N([C@H](CC1CCCCC1)C2=CC=CC=N2)C=3OC=4C(N3)=CC(C)=CC4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Lp-PLA2-IN-1

    Lp-PLA2 -IN-1 suppresses Lp-PLA2 activity processes for their preparation.

  • CCT129957

    CCT129957 is a novel and potent phospholipase C-γ (PLC-γ) inhibitor with an IC50 of about 3 μM and a GC50 of 15 μM.CCT129957 exhibits anticancer activity and inhibits Ca2+ release in squamous cells.

  • MAFP

    MAFP (Methyl Arachidonyl Fluorophosphonate) is an effective, active-site directed irreversible inhibitor of anandamide amidase, cPLA2, and iPLA2.